Shopping Cart 0
Cart Subtotal
AED 0

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

University of Texas MD Anderson Cancer Center-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Aug 26,2019: Genetic cues to ovarian cancer explored

Aug 22,2019: MD Anderson receives USD 55 million over five years in comprehensive cancer center status renewal

Aug 21,2019: MD Anderson receives more than USD 19 million in CPRIT funding

Aug 14,2019: Boehringer partners with MD Anderson on virtual R&D centre

Jul 15,2019: New biomarker-guided strategy has potential for liver cancer treatment

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

University of Texas MD Anderson Cancer Center-Key Facts

University of Texas MD Anderson Cancer Center-Key Employees

University of Texas MD Anderson Cancer Center-Key Employee Biographies

University of Texas MD Anderson Cancer Center-Major Products and Services

University of Texas MD Anderson Cancer Center-History

University of Texas MD Anderson Cancer Center-Company Statement

University of Texas MD Anderson Cancer Center-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

University of Texas MD Anderson Cancer Center-Business Description

Business Segment: Auxillary Income

Performance

Business Segment: Investment and Other Non-operating Income

Performance

Business Segment: Net Patient Revenue

Performance

Business Segment: Other Income

Performance

Business Segment: Restricted Grants and Contracts, Philanthropy

Performance

Business Segment: State-appropriated General Revenue

Performance

R&D Overview

University of Texas MD Anderson Cancer Center-Corporate Strategy

University of Texas MD Anderson Cancer Center-SWOT Analysis

SWOT Analysis-Overview

University of Texas MD Anderson Cancer Center-Strengths

University of Texas MD Anderson Cancer Center-Weaknesses

University of Texas MD Anderson Cancer Center-Opportunities

University of Texas MD Anderson Cancer Center-Threats

University of Texas MD Anderson Cancer Center-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 26, 2019: Genetic cues to ovarian cancer explored

Aug 22, 2019: MD Anderson receives USD 55 million over five years in comprehensive cancer center status renewal

Aug 21, 2019: MD Anderson receives more than USD 19 million in CPRIT funding

Aug 14, 2019: Boehringer partners with MD Anderson on virtual R&D centre

Jul 15, 2019: New biomarker-guided strategy has potential for liver cancer treatment

Jun 21, 2019: AACR conference features latest research on impact of environmental carcinogens and potential pathways to cancer prevention

Jun 10, 2019: Study finds macrophages' pathway to nurture PTEN-deficient glioblastoma

May 02, 2019: New cancer therapy target found in mitochondria for potential treatment of blood cancers

Mar 27, 2019: New potential therapeutic target for pancreatic cancer discovered

Mar 20, 2019: NCCN announces six quality improvement projects in Gastric Cancer care approved for collaboration with Lilly Oncology

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

University of Texas MD Anderson Cancer Center, Key Facts

University of Texas MD Anderson Cancer Center, Key Employees

University of Texas MD Anderson Cancer Center, Key Employee Biographies

University of Texas MD Anderson Cancer Center, Major Products and Services

University of Texas MD Anderson Cancer Center, History

University of Texas MD Anderson Cancer Center, Other Locations

University of Texas MD Anderson Cancer Center, Subsidiaries

University of Texas MD Anderson Cancer Center, Joint Venture

University of Texas MD Anderson Cancer Center, Key Competitors

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

University of Texas MD Anderson Cancer Center, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

TIRR Memorial Hermann

Texas Children's Cancer Center

Houston Methodist Hospital

Cancer Therapy and Research Center

Baylor St Luke's Medical Center

Company Profile

Company Profile Title

University of Texas MD Anderson Cancer Center-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Aug 26,2019: Genetic cues to ovarian cancer explored

Aug 22,2019: MD Anderson receives USD 55 million over five years in comprehensive cancer center status renewal

Aug 21,2019: MD Anderson receives more than USD 19 million in CPRIT funding

Aug 14,2019: Boehringer partners with MD Anderson on virtual R&D centre

Jul 15,2019: New biomarker-guided strategy has potential for liver cancer treatment

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

University of Texas MD Anderson Cancer Center-Key Facts

University of Texas MD Anderson Cancer Center-Key Employees

University of Texas MD Anderson Cancer Center-Key Employee Biographies

University of Texas MD Anderson Cancer Center-Major Products and Services

University of Texas MD Anderson Cancer Center-History

University of Texas MD Anderson Cancer Center-Company Statement

University of Texas MD Anderson Cancer Center-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

University of Texas MD Anderson Cancer Center-Business Description

Business Segment: Auxillary Income

Performance

Business Segment: Investment and Other Non-operating Income

Performance

Business Segment: Net Patient Revenue

Performance

Business Segment: Other Income

Performance

Business Segment: Restricted Grants and Contracts, Philanthropy

Performance

Business Segment: State-appropriated General Revenue

Performance

R&D Overview

University of Texas MD Anderson Cancer Center-Corporate Strategy

University of Texas MD Anderson Cancer Center-SWOT Analysis

SWOT Analysis-Overview

University of Texas MD Anderson Cancer Center-Strengths

University of Texas MD Anderson Cancer Center-Weaknesses

University of Texas MD Anderson Cancer Center-Opportunities

University of Texas MD Anderson Cancer Center-Threats

University of Texas MD Anderson Cancer Center-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 26, 2019: Genetic cues to ovarian cancer explored

Aug 22, 2019: MD Anderson receives USD 55 million over five years in comprehensive cancer center status renewal

Aug 21, 2019: MD Anderson receives more than USD 19 million in CPRIT funding

Aug 14, 2019: Boehringer partners with MD Anderson on virtual R&D centre

Jul 15, 2019: New biomarker-guided strategy has potential for liver cancer treatment

Jun 21, 2019: AACR conference features latest research on impact of environmental carcinogens and potential pathways to cancer prevention

Jun 10, 2019: Study finds macrophages' pathway to nurture PTEN-deficient glioblastoma

May 02, 2019: New cancer therapy target found in mitochondria for potential treatment of blood cancers

Mar 27, 2019: New potential therapeutic target for pancreatic cancer discovered

Mar 20, 2019: NCCN announces six quality improvement projects in Gastric Cancer care approved for collaboration with Lilly Oncology

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

University of Texas MD Anderson Cancer Center, Key Facts

University of Texas MD Anderson Cancer Center, Key Employees

University of Texas MD Anderson Cancer Center, Key Employee Biographies

University of Texas MD Anderson Cancer Center, Major Products and Services

University of Texas MD Anderson Cancer Center, History

University of Texas MD Anderson Cancer Center, Other Locations

University of Texas MD Anderson Cancer Center, Subsidiaries

University of Texas MD Anderson Cancer Center, Joint Venture

University of Texas MD Anderson Cancer Center, Key Competitors

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

University of Texas MD Anderson Cancer Center, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

University of Texas MD Anderson Cancer Center, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

TIRR Memorial Hermann

Texas Children's Cancer Center

Houston Methodist Hospital

Cancer Therapy and Research Center

Baylor St Luke's Medical Center